Worldwide Medical and Safety, Pfizer Research and Development, Pfizer Inc, New York, NY, United States.
Pfizer Research and Development UK Ltd, Cambridge, United Kingdom.
JMIR Med Inform. 2024 Sep 30;12:e64143. doi: 10.2196/64143.
Cardiovascular drug development requires synthesizing relevant literature about indications, mechanisms, biomarkers, and outcomes. This short study investigates the performance, cost, and prompt engineering trade-offs of 3 large language models accelerating the literature screening process for cardiovascular drug development applications.
心血管药物研发需要综合相关文献,包括适应证、作用机制、生物标志物和结局。这项简短的研究调查了 3 种大型语言模型在加速心血管药物研发应用文献筛选过程中的性能、成本和快速工程权衡。